ribozyme therapy (Innovir Laboratories)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Nameribozyme therapy (Innovir Laboratories)

Drug Alias Nameantibacterial agents (Innovir)FRS technology (Innovir)Functional Ribozyme Selection Technology

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInnovir Laboratories Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInnovir Laboratories Inc

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A